Immunodominant sites of HTLV-I envelope protein

Details Immunodominant sites of HTLV-I envelope protein Immunodominant sites of HTLV-I envelope protein

1995-06-06

1997-12-09

Adams, Donald E.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

4241851, 4241861, 4241871, 4241931, 42419611, 530324, 530325, 530326, 530327, 530402, 530403, 530806, 530826, A61K 3921

Patent

active

056957629

ABSTRACT:
The invention resides in various peptides derived from the envelope glycoprotein of HTLV-1 and conjugates of the peptides. Compositions including the peptides are also included in the invention. The peptides, their conjugates and compositions thereof have use in diagnostic and immunization methods, especially those that are based upon T-helper and/or cytotoxic T lymphocyte function.

REFERENCES:
patent: 4525300 (1985-06-01), Yoshida et al.
patent: 4663436 (1987-05-01), Elder et al.
patent: 4689398 (1987-08-01), Wu et al.
patent: 4724258 (1988-02-01), Yoshida et al.
patent: 4822606 (1989-04-01), Snyderman et al.
patent: 4833071 (1989-05-01), Wang et al.
patent: 4879212 (1989-11-01), Wang et al.
patent: 5017687 (1991-05-01), Vahlne et al.
patent: 5066579 (1991-11-01), Reyes
patent: 5476765 (1995-12-01), Wang
Townsend et al. "Antigen Recognition by Class I-Restricted T Lymphocytes" in Annual Review of Immunology, vol. 7, (1989), edited by Paul et al, published by Annual Reviews Inc. Palo Alto, CA, pp. 601-624. QR180.A5.
Townsend et al. "The Epitopes of Influenza Nucleoprotein Recognized by Cytotoxic T Lymphocytes can be Defined with Short Synthetic Peptides", Cell, vol. 44(Mar. 28, 1986), pp. 959-968. QH573.C38.
Tanaka et al., Journal of Immunology, vol. 147, No. 1, pp. 354-360 (1991).
Kiyokawa et al., Proc. Natl. Acad. Sci., USA, vol. 81, pp. 6202-6206 (1984).
Harlow et al., "Antibodies a Lab Manual", Cold Spring, Harbor, New York, pp. 130-132.
Atassi et al., "Antigen Specific T Cell Receptors and Factors," Ed. J.J. Machalonis, CRC Press, Boca Roton, Florida, pp. 7-63.
Palker et al., "Mapping of Immunogen Regions of (HTLV-1) gp 46 and gp21 Envelope with env encoded synthetic peptide and monoclonal antibody to gp46," Journal of Immunology, vol. 142(3), pp. 971-978 (1989).
Malik et al., J. Gen. Vir., vol. 69, pp. 1695-1710 (1988).
Nakamur et al., Int. J. Cancer, vol. 40, pp. 403-407 (1987).
Gazzolo et al., "Direct Activation of Resting T Lymphocytes by Human T-lymphotrophic Virus Type I," Nature, vol. 326, pp. 714-717 (1987).
Harlow et al., "Antibodies: a Laboratory Manual," Cold Spring Harbor, New York, pp. 99 (1988).

Affiliated with

Also associated with

Rating

Immunodominant sites of HTLV-I envelope protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunodominant sites of HTLV-I envelope protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunodominant sites of HTLV-I envelope protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1605584